Kivu's Latest News

Latest news and press releases

In the News

FirstWord Pharma |
October 28, 2024

Backed by Novo, Kivu debuts with $92M to build ‘kinder, gentler’ medicines

“Kivu’s two-part goal is simple: achieve the highest ADC concentration possible within the tumour microenvironment, while minimising dose reductions and treatment interruptions.” Elizabeth S. Eaton, FirstWord Pharma

Biopharma Dive |
October 28, 2024

With $92M, Kivu sets out to make ‘kinder, gentler’ ADCs

“The startup, which is backed by Novo Holdings and a handful of other venture firms, is the latest to capitalize on interest in the targeted cancer drugs.” Gwendolyn Wu, Biopharma Dive

Press Releases